In Vitro & In Vivo Diagnostic Substances
15 stocks in Healthcare & Pharma · SIC 2835.
Company snapshot 2026-10-09 · Calculated market cap as of 2026-10-02 · USD
| Ticker | Company | Market Cap | Revenue (TTM) | Net Income (TTM) |
|---|---|---|---|---|
| IDXX | IDEXX LABORATORIES INC /DE | $40.79B | $4.55BTTM ended 2026-06-30 | $1.14BTTM ended 2026-06-30 |
| LNTH | Lantheus Holdings, Inc. | $6.50B | $1.56BTTM ended 2026-06-30 | $275.31MTTM ended 2026-06-30 |
| NEOG | NEOGEN CORP | $2.67B | $870.40MTTM ended 2026-05-31 | −$7.90MTTM ended 2026-05-31 |
| CLDX | Celldex Therapeutics, Inc. | $2.53B | $158.00KTTM ended 2026-06-30 | −$300.55MTTM ended 2026-06-30 |
| NTLA | Intellia Therapeutics, Inc. | $1.70B | $59.51MTTM ended 2026-06-30 | −$399.98MTTM ended 2026-06-30 |
| ACHV | ACHIEVE LIFE SCIENCES, INC. | $774.86M | — | −$114.04MTTM ended 2026-06-30 |
| QDEL | QuidelOrtho Corp | $711.81M | $2.67BTTM ended 2026-06-28 | −$1.05BTTM ended 2026-06-28 |
| TKNO | Alpha Teknova, Inc. | $475.68M | $43.70MTTM ended 2026-06-30 | −$16.77MTTM ended 2026-06-30 |
| MYGN | MYRIAD GENETICS INC | $388.34M | $806.60MTTM ended 2026-06-30 | −$112.60MTTM ended 2026-06-30 |
| IMDX | Insight Molecular Diagnostics Inc. | $113.55M | $1.67MTTM ended 2026-06-30 | −$49.36MTTM ended 2026-06-30 |
| ICCC | IMMUCELL CORP /DE/ | $87.19M | $30.68MTTM ended 2026-06-30 | $787.37KTTM ended 2026-06-30 |
| BMRA | BIOMERICA INC | $10.30M | $4.45MTTM ended 2026-05-31 | −$3.77MTTM ended 2026-05-31 |
| QCLS | Q/C TECHNOLOGIES, INC. | $6.35M | — | −$16.57MTTM ended 2026-06-30 |
| CDIO | Cardio Diagnostics Holdings, Inc. | $5.68M | $14.45KTTM ended 2026-06-30 | −$6.47MTTM ended 2026-06-30 |
| VNRX | VOLITIONRX LTD | $3.14M | $2.46MTTM ended 2026-06-30 | −$25.64MTTM ended 2026-06-30 |
No matching companies.